May 2003
Volume 44, Issue 13
ARVO Annual Meeting Abstract  |   May 2003
Differential Expression of Connective Tissue Growth Factor in Microglia and Pericytes in the Human Diabetic Retina
Author Affiliations & Notes
  • E.J. Kuiper
    Ophthalmology, IOI/AMC, Amsterdam, Netherlands
  • A.N. Witmer
    Ophthalmology, IOI/AMC, Amsterdam, Netherlands
  • I. Klaassen
    Ophthalmology, IOI/AMC, Amsterdam, Netherlands
  • C. Trischberger
    Pathology, UMC, Utrecht, Netherlands
  • N. Oliver
    Fibrogen, inc., San Francisco, CA, United States
  • R.O. Schlingemann
    Fibrogen, inc., San Francisco, CA, United States
  • R. Goldschmeding
    Fibrogen, inc., San Francisco, CA, United States
  • Footnotes
    Commercial Relationships  E.J. Kuiper, None; A.N. Witmer, None; I. Klaassen, None; C. Trischberger, None; N. Oliver, None; R.O. Schlingemann, Fibrogen F; R. Goldschmeding, Fibrogen F.
  • Footnotes
    Support  support Diabetes Fonds grant 2001.042
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 3887. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E.J. Kuiper, A.N. Witmer, I. Klaassen, C. Trischberger, N. Oliver, R.O. Schlingemann, R. Goldschmeding; Differential Expression of Connective Tissue Growth Factor in Microglia and Pericytes in the Human Diabetic Retina . Invest. Ophthalmol. Vis. Sci. 2003;44(13):3887.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose. Connective tissue growth factor (CTGF) stimulates fibrosis and angiogenesis and has a role in the pathogenesis of diabetic nephropathy. In cultured retinal vascular cells CTGF is induced by VEGF-A, indicating a possible role of CTGF in diabetic retinopathy (DR). To further characterize this role we investigated CTGF expression in normal and diabetic human retina. Methods. CTGF expression patterns were studied by immunohistochemistry in the retina of eyes of 36 diabetic patients and 18 non-diabetic controls and compared with staining of markers of endothelial cells (CD31), pericytes (NG2), astrocytes (GFAP) and microglia (CD45). Results. In control retinas and in 16 out of the 36 diabetic cases, distinct, specific and predominant staining of CTGF was observed in microglia, situated around or in close vicinity of retinal capillaries. In addition, within the vascular wall, sporadic staining of pericytes was also observed. In contrast, in the retina of 20 out of 36 persons with diabetes, pericytes were the predominant cell type expressing CTGF. Conclusions. Our study shows for the first time that CTGF is expressed in microglia in the retina. In a large subset of diabetic persons, CTCF is predominantly expressed in microvascular pericytes. This may parallel the reported VEGF- and glucose-induced CTGF expression in retinal pericytes and glomerular mesangial cell in vitro, respectively. Our results suggest a distinct, but as yet unidentified, role of CTGF in the pathogenesis of diabetic retinopathy.

Keywords: growth factors/growth factor receptors • diabetic retinopathy • immunohistochemistry 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.